rs185957513

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001110792.2(MECP2):​c.1409G>A​(p.Arg470His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000191 in 1,209,420 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 88 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R470C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., 8 hem., cov: 22)
Exomes 𝑓: 0.00019 ( 0 hom. 80 hem. )

Consequence

MECP2
NM_001110792.2 missense

Scores

2
7
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 2.70
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.056291252).
BP6
Variant X-154030455-C-T is Benign according to our data. Variant chrX-154030455-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 95193.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154030455-C-T is described in Lovd as [Likely_benign]. Variant chrX-154030455-C-T is described in Lovd as [Pathogenic]. Variant chrX-154030455-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.000194 (213/1098179) while in subpopulation EAS AF= 0.000894 (27/30206). AF 95% confidence interval is 0.00063. There are 0 homozygotes in gnomad4_exome. There are 80 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 8 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MECP2NM_001110792.2 linkuse as main transcriptc.1409G>A p.Arg470His missense_variant 3/3 ENST00000453960.7
MECP2NM_004992.4 linkuse as main transcriptc.1373G>A p.Arg458His missense_variant 4/4 ENST00000303391.11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MECP2ENST00000453960.7 linkuse as main transcriptc.1409G>A p.Arg470His missense_variant 3/31 NM_001110792.2 P51608-2
MECP2ENST00000303391.11 linkuse as main transcriptc.1373G>A p.Arg458His missense_variant 4/41 NM_004992.4 P1P51608-1
MECP2ENST00000628176.2 linkuse as main transcriptc.*745G>A 3_prime_UTR_variant 5/53

Frequencies

GnomAD3 genomes
AF:
0.000171
AC:
19
AN:
111191
Hom.:
0
Cov.:
22
AF XY:
0.000240
AC XY:
8
AN XY:
33373
show subpopulations
Gnomad AFR
AF:
0.000131
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000950
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000566
Gnomad SAS
AF:
0.000779
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000189
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000229
AC:
42
AN:
183515
Hom.:
0
AF XY:
0.000294
AC XY:
20
AN XY:
67943
show subpopulations
Gnomad AFR exome
AF:
0.0000760
Gnomad AMR exome
AF:
0.000109
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00173
Gnomad SAS exome
AF:
0.000419
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000732
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000194
AC:
213
AN:
1098179
Hom.:
0
Cov.:
32
AF XY:
0.000220
AC XY:
80
AN XY:
363533
show subpopulations
Gnomad4 AFR exome
AF:
0.0000758
Gnomad4 AMR exome
AF:
0.000284
Gnomad4 ASJ exome
AF:
0.000103
Gnomad4 EAS exome
AF:
0.000894
Gnomad4 SAS exome
AF:
0.000222
Gnomad4 FIN exome
AF:
0.0000247
Gnomad4 NFE exome
AF:
0.000175
Gnomad4 OTH exome
AF:
0.000239
GnomAD4 genome
AF:
0.000162
AC:
18
AN:
111241
Hom.:
0
Cov.:
22
AF XY:
0.000239
AC XY:
8
AN XY:
33433
show subpopulations
Gnomad4 AFR
AF:
0.000131
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000568
Gnomad4 SAS
AF:
0.000781
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000189
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000759
Hom.:
0
Bravo
AF:
0.000170
ExAC
AF:
0.000206
AC:
25
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jan 28, 2013- -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoFeb 08, 2013- -
Benign, no assertion criteria providedcurationRettBASENov 05, 2009- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxNov 08, 2018This variant is associated with the following publications: (PMID: 18810657, 28394482) -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenDec 01, 2021- -
Rett syndrome Benign:1
Benign, criteria provided, single submittercurationCentre for Population Genomics, CPGAug 14, 2023This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria.Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 2.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 2.0 (BA1). The variant is observed in at least 2 individuals with no features of Rett Syndrome (BS2, PMID 18810657, PMID: 18810657). Variant found in a case with an alternate molecular basis for disease (BP5_Supporting, PMID: 18810657). -
Severe neonatal-onset encephalopathy with microcephaly Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 27, 2024- -
Rett syndrome;C0796222:X-linked intellectual disability-psychosis-macroorchidism syndrome;C1845336:Autism, susceptibility to, X-linked 3;C1846058:Syndromic X-linked intellectual disability Lubs type;C1968556:Severe neonatal-onset encephalopathy with microcephaly Benign:1
Likely benign, criteria provided, single submitterclinical testingCenter for Genomics, Ann and Robert H. Lurie Children's Hospital of ChicagoMar 30, 2021MECP2 NM_004992.3 exon 4 p.Arg458His (c.1373G>A): This variant has been reported in the literature in 1 male individual with features of Rett syndrome, but did not meet diagnostic criteria (reported as p.Arg470His, Zhang 2017 PMID:28394482). This variant is present in 0.01% (10/52947) of European alleles, including 5 hemizygotes in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/X-154030455-C-T?dataset=gnomad_r3). This variant is present in ClinVar, with several labs classifying this variant as Benign (Variation ID:95193). Evolutionary conservation suggests that this variant may impact the protein; computational predictive tools for this variant are unclear. In summary, data on this variant suggests that this variant does not cause disease, but requires further evidence. Therefore this variant is classified as likely benign. -
MECP2-related disorder Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesJun 03, 2021This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.040
T
BayesDel_noAF
Pathogenic
0.15
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.37
T;.
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.95
D;D
M_CAP
Pathogenic
0.37
D
MetaRNN
Benign
0.056
T;T
MetaSVM
Uncertain
0.41
D
MutationAssessor
Benign
0.90
L;.
MutationTaster
Benign
0.99
D;D
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-0.93
N;N
REVEL
Uncertain
0.47
Sift
Uncertain
0.0070
D;D
Sift4G
Benign
0.14
T;T
Polyphen
1.0
D;D
Vest4
0.19
MVP
0.98
ClinPred
0.032
T
GERP RS
5.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.24
gMVP
0.15

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs185957513; hg19: chrX-153295906; COSMIC: COSV57654203; COSMIC: COSV57654203; API